Aerolase Wins 2025 MedEsthetics Readers' Choice Awards: Neo Elite Named Best Acne Device, Era Elite Recognized for Laser Skin Resurfacing

In the inaugural 2025 MedEsthetics Readers' Choice Awards, Neo Elite® won Best Acne Device while Era Elite® earned finalist recognition for Best Laser Skin Resurfacing Device¹—representing validation from 15,000 aesthetic professionals including dermatologists, plastic surgeons, and medical aestheticians who voted based on real-world clinical outcomes.

Why Neo Elite Won Best Acne Device

Neo Elite's recognition reflects its ability to deliver transformative acne clearance without systemic medication risks. A peer-reviewed clinical study published in the Journal of Drugs in Dermatology and led by renowned dermatologist Dr. Nazanin Saedi demonstrates²:

• 84% reduction in acne lesions by the end of the treatment course
• 87% reduction maintained at 90-day follow-up
• 80% of patients avoided isotretinoin (Accutane), eliminating concerns about documented side effects including birth defects and depression

For dermatologists managing difficult acne cases, Neo Elite provides a clinically validated alternative with comparable results and no systemic exposure.

The Technology Behind the Results

Neo Elite's patented 650-microsecond 1064nm Nd:YAG laser technology¹ addresses acne through three simultaneous mechanisms: sebum reduction, inflammation control, and bacterial elimination targeting Cutibacterium acnes². The microsecond pulse duration prevents thermal damage while enabling safe treatment across all Fitzpatrick skin types without hyperpigmentation risk³.

Comprehensive Treatment Approach

Neo Elite treats the complete spectrum of acne-related concerns in a single session: post-inflammatory erythema (PIE), post-inflammatory hyperpigmentation (PIH), and acne scarring¹. By stimulating collagen production through bulk heating of dermal water, it simultaneously improves skin texture while clearing active lesions.

Patient outcomes demonstrate exceptional tolerability and satisfaction²:

• 90-95% patient satisfaction rates
• 94% reported improved self-esteem and confidence
• Average pain score of 2/10
• No anesthesia required
• No downtime affecting daily activities

Era Elite: Finalist for Best Laser Skin Resurfacing Device

Era Elite's recognition highlights a fundamental innovation: it's the only erbium laser that creates ablation without collateral thermal damage¹. Traditional ablative erbium lasers require anesthesia, aggressive cooling, and extended recovery. Era Elite's 300-microsecond pulse duration at 2940nm wavelength¹ provides controlled ablation without thermal injury, enabling a "lunchtime peel" experience.

Clinical Evidence for All Skin Types

A study at Howard University Medical School demonstrated Era Elite's unique safety and efficacy on Fitzpatrick Types V and VI¹—expanding best-practice dermatology to previously underserved populations with darker skin tones. The device offers both full-field resurfacing and hybrid fractional treatment modes⁴, providing versatility without requiring separate laser systems.

The Synergistic Combination: Neo Elite + Era Elite

Research presented at the American Society for Laser Medicine and Surgery (ASLMS) demonstrated enhanced outcomes when combining both devices—creating what researchers call a "regenerative neocollagenesis powerhouse"¹.

A clinical study of 25 patients (aged 38-61) showed¹:

• 86% with significant increases in Type III collagen production
• 57% with notable Type I collagen increases one month post-treatment
• Increased collagen density around skin appendages
• Improved structure of lymphatic and arterial vessels
• More organized elastic fibers in the upper dermis
• Minimal erythema and swelling, no significant adverse events

How the Dual Protocol Works

The combination targets both deep and superficial dermal layers synergistically¹:

Neo Elite (650-microsecond 1064nm Nd:YAG): Penetrates deep to stimulate collagen production, enhance microvascular health, and address inflammatory conditions including acne and rosacea.

Era Elite (300-microsecond 2940nm Er:YAG): Addresses superficial concerns including fine lines, texture, and tone while promoting controlled renewal of upper dermal layers.

Dr. Michael Gold, a Key Opinion Leader and dermatologist who has extensively studied both technologies, notes: "The combination of Neo Elite and Era Elite represents a paradigm shift in how we approach skin rejuvenation. We're seeing remarkable improvements in collagen synthesis, vascular health, and overall skin quality, all achieved in a single, comfortable session with minimal downtime."¹

What These Awards Mean for Your Practice

MedEsthetics Readers' Choice Awards reflect voting by practicing aesthetic professionals who evaluate devices based on clinical outcomes, patient satisfaction, and return on investment⁵. This reader-driven format provides meaningful peer validation for practitioners researching technology investments.

Pavel Efremkin, PhD, Founder and CEO of Aerolase, emphasizes the significance: "Neo Elite delivers what patients and practitioners need most—exceptional results without the pain, downtime, or limitations of traditional acne treatments. This award reflects the confidence that thousands of providers place in Neo Elite to deliver life-changing outcomes for their acne patients."¹

Expanding Access Through Technology

Both devices address a critical barrier in aesthetic medicine: treatment accessibility for diverse patient populations. Their safety across all Fitzpatrick skin types³, combined with minimal discomfort and downtime, expands the addressable patient population for practices serving diverse communities or working professionals who cannot accommodate extended recovery periods.

Conclusion

The 2025 MedEsthetics Readers' Choice Awards validate Aerolase's regenerative laser technology approach, with peer recognition from 15,000 aesthetic professionals confirming what clinicians experience in practice: exceptional clinical outcomes without compromising patient safety or comfort.

References

1. Aerolase Corporation. (December 9, 2025). "Aerolase Earns Dual Honors in MedEsthetics 2025 Readers' Choice Awards." PR Newswire. Retrieved from https://www.prnewswire.com/news-releases/aerolase-earns-dual-honors-in-medesthetics-2025-readers-choice-awards-302637396.html
2. Saedi, N., Griffin, T. Jr., & Kelly, S. (2024). "Treatment of Mild to Severe Acne Vulgaris with a 650-Microsecond 1064-nm Nd:YAG Laser." Journal of Drugs in Dermatology. Referenced in: https://www.prnewswire.com/news-releases/expert-study-reveals-groundbreaking-results-in-mild-to-severe-acne-treatment-on-skin-types-i-to-vi-with-aerolase-neo-elite-laser-302303024.html
3. Aerolase Corporation. "Leading device-based efficacy: acne clearance with Aerolase Neo Elite." MedEsthetics Magazine. Retrieved from https://www.medestheticsmag.com/treatments/article/22920333/aerolase-company-leading-devicebased-efficacy-acne-clearance-with-aerolase-neo-elite
4. Aerolase Corporation. "Transform Your Skin with Era Elite® Laser Treatment." Retrieved from https://www.aerolase.com/era
5. MedEsthetics Magazine. (November 20, 2025). "Meet the Winners of the 2025 MedEsthetics Readers' Choice Awards." Retrieved from https://www.medestheticsmag.com/companies/article/22952040/meet-the-winners-of-the-2025-medesthetics-readers-choice-awards